Bausch+Lomb IPO Presentation Deck

IPO Offering Summary Issuer Ticker / Exchange Base Offering Size Filing Range Gross Proceeds Overallotment Option Expected Pricing Use of Proceeds Lock-Up Lead Bookrunners Joint Bookrunners Co-Managers BAUSCH + LOMB Bausch + Lomb Corporation BLCO/NYSE and TSX¹ 35,000,000 $21.00 $24.00 $735MM - $840MM ($845MM - $966MM incl. overallotment) 15% (100% Secondary) May 5th, 2022 All proceeds will be received by a wholly-owned subsidiary of Bausch Health Companies, Inc. ("BHC") 125 days for BHC, directors and executive officers, subject to price-based early release Morgan Stanley, Goldman Sachs & Co. LLC Citigroup, J.P. Morgan, Barclays, BofA Securities, Guggenheim Securities, Jefferies, Evercore ISI, Wells Fargo Securities, Deutsche Bank Securities DNB Markets, HSBC, Truist Securities, AmeriVet Securities, Loop Capital Markets, Ramirez & Co., Inc., R. Seelaus & Co., LLC, Siebert Williams Shank, Stern 1. Listing is subject to the approval of the NYSE and TSX in accordance with their initial listing requirements. The TSX has not conditionally approved the listing application and there is no assurance that the TSX will approve the listing application, 3

View entire presentation